PremiumThe FlyEnzo Biochem reports Q2 revenue $7.3M vs. $6.2M in Q1 Enzo Biochem Faces NYSE Compliance Challenges NYSE notifies Enzo Biochem not in compliance with certain requirements PremiumCompany AnnouncementsEnzo Biochem Enhances CFO Patricia Eckert’s Compensation Package Enzo Biochem reports Q3 adjusted EPS (3c) vs. (7c) last year Enzo Biochem Executives Receive Raises and Equity Rewards PremiumThe FlyEnzo Biochem reports Q4 revenue improved sequentially by 20% Enzo Biochem announces resignation of CEO Hamid Erfanian Enzo Biochem jumps over 10% after announcing asset sale to Labcorp